Company / Free Cash Flow per Share
AGIOS PHARMACEUTICALS, INC. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$6.60
FY2025
5-year range
-$7.00 / -$5.40
FY2021-FY2025
Trend
+5.7%
vs FY2024
Sector context
#185 of 192
Health Care
What the data says
Among 192 Health Care companies, AGIOS PHARMACEUTICALS, INC. is in the bottom 4% for free cash flow per share. Free Cash Flow per Share has fluctuated over the past 10 years, ranging from $-7.00 in FY2024 to $0.76 in FY2016.
Based on SEC 10-K filings.
-6.60 in FY2025.
Declined from $-5.40 to $-6.60 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 4% in Health CareTop 96% of 192This company -$6.60 Sector average $3.32
▼
-298.9% below sector average
Key checks
Key Insights
- In FY2025, free cash flow per share increased 5.7% year-over-year.
- Ranks #185 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2016.
- Lowest free cash flow per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.83 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$6.60 | +5.7% |
| FY2024 | -$7.00 | -29.7% |
| FY2023 | -$5.40 | +3.8% |
| FY2022 | -$5.61 | +17.9% |
| FY2021 | -$6.83 | -50.1% |
| FY2020 | -$4.55 | +30.7% |
| FY2019 | -$6.57 | -1220.2% |
| FY2018 | $0.59 | +108.5% |
| FY2017 | -$6.87 | -1003.4% |
| FY2016 | $0.76 | +148.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026